nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—PTGS2—muscle cancer	0.279	1	CbGaD
Ibuprofen—ABCC1—Dactinomycin—muscle cancer	0.0681	0.138	CbGbCtD
Ibuprofen—UGT1A1—Etoposide—muscle cancer	0.0467	0.0946	CbGbCtD
Ibuprofen—ABCC1—Vincristine—muscle cancer	0.0419	0.0849	CbGbCtD
Ibuprofen—ABCC1—Etoposide—muscle cancer	0.0384	0.0778	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—muscle cancer	0.0339	0.0687	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—muscle cancer	0.0316	0.064	CbGbCtD
Ibuprofen—PTGS2—Etoposide—muscle cancer	0.0281	0.0569	CbGbCtD
Ibuprofen—ABCC1—Doxorubicin—muscle cancer	0.0262	0.0531	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—muscle cancer	0.0254	0.0514	CbGbCtD
Ibuprofen—PTGS1—Etoposide—muscle cancer	0.0237	0.048	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—muscle cancer	0.0227	0.0459	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—muscle cancer	0.0197	0.04	CbGbCtD
Ibuprofen—ABCB1—Dactinomycin—muscle cancer	0.0164	0.0333	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—muscle cancer	0.0137	0.0278	CbGbCtD
Ibuprofen—CYP2C8—Etoposide—muscle cancer	0.0137	0.0277	CbGbCtD
Ibuprofen—ALB—Methotrexate—muscle cancer	0.0117	0.0237	CbGbCtD
Ibuprofen—ABCB1—Vincristine—muscle cancer	0.0101	0.0205	CbGbCtD
Ibuprofen—ABCB1—Etoposide—muscle cancer	0.00927	0.0188	CbGbCtD
Ibuprofen—ABCB1—Doxorubicin—muscle cancer	0.00632	0.0128	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—muscle cancer	0.00612	0.0124	CbGbCtD
Ibuprofen—FABP2—embryo—muscle cancer	0.00365	0.061	CbGeAlD
Ibuprofen—PPARG—hindlimb—muscle cancer	0.00277	0.0464	CbGeAlD
Ibuprofen—PPARG—appendage—muscle cancer	0.00238	0.0398	CbGeAlD
Ibuprofen—PPARG—Teniposide—Etoposide—muscle cancer	0.00208	1	CbGdCrCtD
Ibuprofen—THBD—smooth muscle tissue—muscle cancer	0.00184	0.0307	CbGeAlD
Ibuprofen—THBD—renal system—muscle cancer	0.00177	0.0295	CbGeAlD
Ibuprofen—UGT2B4—cardiac atrium—muscle cancer	0.00159	0.0266	CbGeAlD
Ibuprofen—PTGS2—hindlimb—muscle cancer	0.00142	0.0237	CbGeAlD
Ibuprofen—THBD—tendon—muscle cancer	0.00138	0.0231	CbGeAlD
Ibuprofen—BCL2—smooth muscle tissue—muscle cancer	0.00129	0.0216	CbGeAlD
Ibuprofen—THBD—vagina—muscle cancer	0.00128	0.0214	CbGeAlD
Ibuprofen—CFTR—renal system—muscle cancer	0.00126	0.0211	CbGeAlD
Ibuprofen—BCL2—renal system—muscle cancer	0.00124	0.0208	CbGeAlD
Ibuprofen—PTGS2—appendage—muscle cancer	0.00122	0.0203	CbGeAlD
Ibuprofen—UGT1A9—renal system—muscle cancer	0.00122	0.0203	CbGeAlD
Ibuprofen—CXCL8—smooth muscle tissue—muscle cancer	0.0012	0.02	CbGeAlD
Ibuprofen—THBD—head—muscle cancer	0.00118	0.0198	CbGeAlD
Ibuprofen—THBD—testis—muscle cancer	0.00114	0.0191	CbGeAlD
Ibuprofen—PLAT—cardiac atrium—muscle cancer	0.00111	0.0186	CbGeAlD
Ibuprofen—UGT2B7—renal system—muscle cancer	0.00098	0.0164	CbGeAlD
Ibuprofen—PLAT—tendon—muscle cancer	0.000972	0.0162	CbGeAlD
Ibuprofen—SLC22A11—renal system—muscle cancer	0.000955	0.016	CbGeAlD
Ibuprofen—BCL2—bone marrow—muscle cancer	0.000941	0.0157	CbGeAlD
Ibuprofen—PLAT—vagina—muscle cancer	0.000902	0.0151	CbGeAlD
Ibuprofen—Carprofen—PTGS2—muscle cancer	0.000875	0.335	CrCbGaD
Ibuprofen—CXCL8—bone marrow—muscle cancer	0.000872	0.0146	CbGeAlD
Ibuprofen—CFTR—head—muscle cancer	0.000843	0.0141	CbGeAlD
Ibuprofen—CXCL8—vagina—muscle cancer	0.000835	0.014	CbGeAlD
Ibuprofen—UGT1A1—renal system—muscle cancer	0.000833	0.0139	CbGeAlD
Ibuprofen—BCL2—head—muscle cancer	0.000833	0.0139	CbGeAlD
Ibuprofen—CFTR—testis—muscle cancer	0.000815	0.0136	CbGeAlD
Ibuprofen—PLAT—testis—muscle cancer	0.000805	0.0135	CbGeAlD
Ibuprofen—BCL2—testis—muscle cancer	0.000805	0.0135	CbGeAlD
Ibuprofen—PPARG—embryo—muscle cancer	0.00079	0.0132	CbGeAlD
Ibuprofen—CXCL8—testis—muscle cancer	0.000745	0.0125	CbGeAlD
Ibuprofen—UGT2B7—testis—muscle cancer	0.000634	0.0106	CbGeAlD
Ibuprofen—PPARG—smooth muscle tissue—muscle cancer	0.000621	0.0104	CbGeAlD
Ibuprofen—SLCO2B1—renal system—muscle cancer	0.000613	0.0103	CbGeAlD
Ibuprofen—PPARG—renal system—muscle cancer	0.000598	0.01	CbGeAlD
Ibuprofen—SLCO1A2—renal system—muscle cancer	0.000564	0.00943	CbGeAlD
Ibuprofen—ABCC4—renal system—muscle cancer	0.000543	0.00908	CbGeAlD
Ibuprofen—Suprofen—PTGS2—muscle cancer	0.000541	0.207	CrCbGaD
Ibuprofen—SLC22A8—renal system—muscle cancer	0.000539	0.00901	CbGeAlD
Ibuprofen—SLCO2B1—tendon—muscle cancer	0.000479	0.008	CbGeAlD
Ibuprofen—PPARG—tendon—muscle cancer	0.000467	0.0078	CbGeAlD
Ibuprofen—Fenoprofen—PTGS2—muscle cancer	0.000466	0.179	CrCbGaD
Ibuprofen—PPARG—bone marrow—muscle cancer	0.000452	0.00756	CbGeAlD
Ibuprofen—PPARG—vagina—muscle cancer	0.000433	0.00724	CbGeAlD
Ibuprofen—Naproxen—PTGS2—muscle cancer	0.000424	0.163	CrCbGaD
Ibuprofen—ABCC4—tendon—muscle cancer	0.000424	0.00709	CbGeAlD
Ibuprofen—ABCC1—cardiac atrium—muscle cancer	0.000415	0.00693	CbGeAlD
Ibuprofen—ABCC4—bone marrow—muscle cancer	0.000411	0.00686	CbGeAlD
Ibuprofen—SLCO2B1—head—muscle cancer	0.00041	0.00686	CbGeAlD
Ibuprofen—PTGS2—embryo—muscle cancer	0.000404	0.00675	CbGeAlD
Ibuprofen—PPARG—head—muscle cancer	0.0004	0.00669	CbGeAlD
Ibuprofen—SLCO2B1—testis—muscle cancer	0.000396	0.00663	CbGeAlD
Ibuprofen—CYP2C8—renal system—muscle cancer	0.000394	0.00659	CbGeAlD
Ibuprofen—PPARG—testis—muscle cancer	0.000387	0.00646	CbGeAlD
Ibuprofen—SLCO1A2—head—muscle cancer	0.000378	0.00631	CbGeAlD
Ibuprofen—SLCO1A2—testis—muscle cancer	0.000365	0.0061	CbGeAlD
Ibuprofen—ABCC4—head—muscle cancer	0.000363	0.00607	CbGeAlD
Ibuprofen—ALB—testis—muscle cancer	0.000363	0.00606	CbGeAlD
Ibuprofen—ABCC1—tendon—muscle cancer	0.000361	0.00604	CbGeAlD
Ibuprofen—SLC22A8—head—muscle cancer	0.000361	0.00603	CbGeAlD
Ibuprofen—ABCC4—testis—muscle cancer	0.000351	0.00587	CbGeAlD
Ibuprofen—ABCC1—vagina—muscle cancer	0.000335	0.00561	CbGeAlD
Ibuprofen—PTGS1—smooth muscle tissue—muscle cancer	0.000332	0.00555	CbGeAlD
Ibuprofen—CYP2C19—vagina—muscle cancer	0.000327	0.00547	CbGeAlD
Ibuprofen—PTGS1—renal system—muscle cancer	0.00032	0.00535	CbGeAlD
Ibuprofen—PTGS2—smooth muscle tissue—muscle cancer	0.000318	0.00531	CbGeAlD
Ibuprofen—PTGS2—renal system—muscle cancer	0.000306	0.00511	CbGeAlD
Ibuprofen—Flurbiprofen—PTGS2—muscle cancer	0.000304	0.116	CrCbGaD
Ibuprofen—ABCC1—testis—muscle cancer	0.000299	0.005	CbGeAlD
Ibuprofen—PTGS1—cardiac atrium—muscle cancer	0.000286	0.00479	CbGeAlD
Ibuprofen—CYP2C8—vagina—muscle cancer	0.000286	0.00477	CbGeAlD
Ibuprofen—CYP2C8—testis—muscle cancer	0.000255	0.00426	CbGeAlD
Ibuprofen—ABCB1—embryo—muscle cancer	0.00025	0.00418	CbGeAlD
Ibuprofen—PTGS1—tendon—muscle cancer	0.00025	0.00417	CbGeAlD
Ibuprofen—PTGS2—tendon—muscle cancer	0.000239	0.00399	CbGeAlD
Ibuprofen—PTGS1—vagina—muscle cancer	0.000232	0.00387	CbGeAlD
Ibuprofen—PTGS2—bone marrow—muscle cancer	0.000231	0.00386	CbGeAlD
Ibuprofen—PTGS2—vagina—muscle cancer	0.000221	0.0037	CbGeAlD
Ibuprofen—PTGS1—head—muscle cancer	0.000214	0.00358	CbGeAlD
Ibuprofen—PTGS1—testis—muscle cancer	0.000207	0.00345	CbGeAlD
Ibuprofen—PTGS2—head—muscle cancer	0.000204	0.00342	CbGeAlD
Ibuprofen—ABCB1—renal system—muscle cancer	0.000189	0.00316	CbGeAlD
Ibuprofen—PLAT—Folate Metabolism—TP53—muscle cancer	0.000174	0.00345	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—CDKN2A—muscle cancer	0.000172	0.00342	CbGpPWpGaD
Ibuprofen—PLAT—Signaling by PDGF—KIT—muscle cancer	0.000171	0.0034	CbGpPWpGaD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—muscle cancer	0.000166	0.00329	CbGpPWpGaD
Ibuprofen—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000166	0.00328	CbGpPWpGaD
Ibuprofen—BCL2—Intrinsic Pathway for Apoptosis—TP53—muscle cancer	0.000163	0.00322	CbGpPWpGaD
Ibuprofen—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.000163	0.00322	CbGpPWpGaD
Ibuprofen—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000162	0.00321	CbGpPWpGaD
Ibuprofen—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.000161	0.0032	CbGpPWpGaD
Ibuprofen—PTGS2—S1P1 pathway—VEGFA—muscle cancer	0.000158	0.00313	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—FOXO1—muscle cancer	0.000157	0.00311	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—CDKN2A—muscle cancer	0.000155	0.00307	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000155	0.00307	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—muscle cancer	0.000155	0.00307	CbGpPWpGaD
Ibuprofen—Constipation—Vincristine—muscle cancer	0.000153	0.00137	CcSEcCtD
Ibuprofen—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.000153	0.00137	CcSEcCtD
Ibuprofen—Diplopia—Doxorubicin—muscle cancer	0.000153	0.00137	CcSEcCtD
Ibuprofen—Asthma—Methotrexate—muscle cancer	0.000153	0.00136	CcSEcCtD
Ibuprofen—Eosinophilia—Methotrexate—muscle cancer	0.000152	0.00135	CcSEcCtD
Ibuprofen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000151	0.003	CbGpPWpGaD
Ibuprofen—Affect lability—Doxorubicin—muscle cancer	0.000151	0.00135	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000151	0.00134	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—MDM2—muscle cancer	0.00015	0.00298	CbGpPWpGaD
Ibuprofen—Pancreatitis—Methotrexate—muscle cancer	0.00015	0.00134	CcSEcCtD
Ibuprofen—Discomfort—Etoposide—muscle cancer	0.00015	0.00133	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—MYOG—muscle cancer	0.000148	0.00294	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Dactinomycin—muscle cancer	0.000148	0.00132	CcSEcCtD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000147	0.00292	CbGpPWpGaD
Ibuprofen—Abdominal discomfort—Methotrexate—muscle cancer	0.000147	0.00131	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Vincristine—muscle cancer	0.000147	0.00131	CcSEcCtD
Ibuprofen—Confusional state—Etoposide—muscle cancer	0.000147	0.00131	CcSEcCtD
Ibuprofen—Pancytopenia—Methotrexate—muscle cancer	0.000145	0.0013	CcSEcCtD
Ibuprofen—Anaphylactic shock—Etoposide—muscle cancer	0.000145	0.0013	CcSEcCtD
Ibuprofen—Mood swings—Doxorubicin—muscle cancer	0.000145	0.00129	CcSEcCtD
Ibuprofen—CXCL8—Cellular responses to stress—HMGA1—muscle cancer	0.000145	0.00288	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—CDKN2A—muscle cancer	0.000145	0.00288	CbGpPWpGaD
Ibuprofen—BCL2—C-MYB transcription factor network—PTGS2—muscle cancer	0.000145	0.00287	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Cancer Pathway—TP53—muscle cancer	0.000145	0.00287	CbGpPWpGaD
Ibuprofen—Infection—Etoposide—muscle cancer	0.000144	0.00129	CcSEcCtD
Ibuprofen—Asthenia—Dactinomycin—muscle cancer	0.000144	0.00128	CcSEcCtD
Ibuprofen—Blood creatinine increased—Doxorubicin—muscle cancer	0.000144	0.00128	CcSEcCtD
Ibuprofen—Dysuria—Methotrexate—muscle cancer	0.000143	0.00128	CcSEcCtD
Ibuprofen—Neutropenia—Methotrexate—muscle cancer	0.000143	0.00128	CcSEcCtD
Ibuprofen—ABCB1—bone marrow—muscle cancer	0.000143	0.00239	CbGeAlD
Ibuprofen—Thrombocytopenia—Etoposide—muscle cancer	0.000142	0.00127	CcSEcCtD
Ibuprofen—PPARG—Regulation of retinoblastoma protein—CDKN2A—muscle cancer	0.000142	0.00282	CbGpPWpGaD
Ibuprofen—Tachycardia—Etoposide—muscle cancer	0.000142	0.00126	CcSEcCtD
Ibuprofen—Abdominal pain—Vincristine—muscle cancer	0.000142	0.00126	CcSEcCtD
Ibuprofen—Liver function test abnormal—Doxorubicin—muscle cancer	0.000142	0.00126	CcSEcCtD
Ibuprofen—Skin disorder—Etoposide—muscle cancer	0.000141	0.00126	CcSEcCtD
Ibuprofen—Erectile dysfunction—Methotrexate—muscle cancer	0.000141	0.00126	CcSEcCtD
Ibuprofen—Hyperhidrosis—Etoposide—muscle cancer	0.000141	0.00125	CcSEcCtD
Ibuprofen—CXCL8—G alpha (i) signalling events—CNR1—muscle cancer	0.00014	0.00278	CbGpPWpGaD
Ibuprofen—Abdominal pain upper—Doxorubicin—muscle cancer	0.00014	0.00125	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Methotrexate—muscle cancer	0.00014	0.00125	CcSEcCtD
Ibuprofen—Hypokalaemia—Doxorubicin—muscle cancer	0.00014	0.00124	CcSEcCtD
Ibuprofen—Anorexia—Etoposide—muscle cancer	0.000139	0.00123	CcSEcCtD
Ibuprofen—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000138	0.00123	CcSEcCtD
Ibuprofen—PPARG—Regulation of retinoblastoma protein—MDM2—muscle cancer	0.000138	0.00274	CbGpPWpGaD
Ibuprofen—ABCC1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000138	0.00273	CbGpPWpGaD
Ibuprofen—Diarrhoea—Dactinomycin—muscle cancer	0.000137	0.00122	CcSEcCtD
Ibuprofen—Pneumonia—Methotrexate—muscle cancer	0.000137	0.00122	CcSEcCtD
Ibuprofen—ABCC4—Fluoropyrimidine Activity—TP53—muscle cancer	0.000137	0.00272	CbGpPWpGaD
Ibuprofen—ABCB1—vagina—muscle cancer	0.000137	0.00229	CbGeAlD
Ibuprofen—UGT2B4—Metabolism—FH—muscle cancer	0.000137	0.00271	CbGpPWpGaD
Ibuprofen—Drowsiness—Methotrexate—muscle cancer	0.000137	0.00122	CcSEcCtD
Ibuprofen—Depression—Methotrexate—muscle cancer	0.000136	0.00121	CcSEcCtD
Ibuprofen—Hypotension—Etoposide—muscle cancer	0.000136	0.00121	CcSEcCtD
Ibuprofen—Gastritis—Doxorubicin—muscle cancer	0.000136	0.00121	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000135	0.00121	CcSEcCtD
Ibuprofen—PLAT—Signaling by PDGF—MDM2—muscle cancer	0.000135	0.00267	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KIDINS220—muscle cancer	0.000135	0.00267	CbGpPWpGaD
Ibuprofen—Renal failure—Methotrexate—muscle cancer	0.000134	0.0012	CcSEcCtD
Ibuprofen—PPARG—Adipogenesis—FOXO1—muscle cancer	0.000134	0.00265	CbGpPWpGaD
Ibuprofen—Abdominal distension—Doxorubicin—muscle cancer	0.000134	0.00119	CcSEcCtD
Ibuprofen—Stomatitis—Methotrexate—muscle cancer	0.000133	0.00119	CcSEcCtD
Ibuprofen—Conjunctivitis—Methotrexate—muscle cancer	0.000133	0.00118	CcSEcCtD
Ibuprofen—Dysphagia—Doxorubicin—muscle cancer	0.000133	0.00118	CcSEcCtD
Ibuprofen—Influenza—Doxorubicin—muscle cancer	0.000133	0.00118	CcSEcCtD
Ibuprofen—Asthma—Doxorubicin—muscle cancer	0.000133	0.00118	CcSEcCtD
Ibuprofen—Hypersensitivity—Vincristine—muscle cancer	0.000132	0.00118	CcSEcCtD
Ibuprofen—Eosinophilia—Doxorubicin—muscle cancer	0.000131	0.00117	CcSEcCtD
Ibuprofen—Sweating—Methotrexate—muscle cancer	0.000131	0.00117	CcSEcCtD
Ibuprofen—Paraesthesia—Etoposide—muscle cancer	0.000131	0.00116	CcSEcCtD
Ibuprofen—Haematuria—Methotrexate—muscle cancer	0.00013	0.00116	CcSEcCtD
Ibuprofen—Pancreatitis—Doxorubicin—muscle cancer	0.00013	0.00116	CcSEcCtD
Ibuprofen—Dyspnoea—Etoposide—muscle cancer	0.00013	0.00115	CcSEcCtD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—CDKN2A—muscle cancer	0.00013	0.00257	CbGpPWpGaD
Ibuprofen—Somnolence—Etoposide—muscle cancer	0.000129	0.00115	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Methotrexate—muscle cancer	0.000129	0.00115	CcSEcCtD
Ibuprofen—Epistaxis—Methotrexate—muscle cancer	0.000129	0.00115	CcSEcCtD
Ibuprofen—Asthenia—Vincristine—muscle cancer	0.000129	0.00115	CcSEcCtD
Ibuprofen—Vomiting—Dactinomycin—muscle cancer	0.000128	0.00114	CcSEcCtD
Ibuprofen—Bronchitis—Doxorubicin—muscle cancer	0.000128	0.00114	CcSEcCtD
Ibuprofen—Agranulocytosis—Methotrexate—muscle cancer	0.000127	0.00114	CcSEcCtD
Ibuprofen—Rash—Dactinomycin—muscle cancer	0.000127	0.00113	CcSEcCtD
Ibuprofen—ABCB1—head—muscle cancer	0.000126	0.00211	CbGeAlD
Ibuprofen—Decreased appetite—Etoposide—muscle cancer	0.000126	0.00113	CcSEcCtD
Ibuprofen—Pancytopenia—Doxorubicin—muscle cancer	0.000126	0.00112	CcSEcCtD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—muscle cancer	0.000126	0.00249	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—MDM2—muscle cancer	0.000126	0.00249	CbGpPWpGaD
Ibuprofen—Gastrointestinal disorder—Etoposide—muscle cancer	0.000126	0.00112	CcSEcCtD
Ibuprofen—Fatigue—Etoposide—muscle cancer	0.000125	0.00112	CcSEcCtD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—CDKN2A—muscle cancer	0.000125	0.00247	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—muscle cancer	0.000125	0.00247	CbGpPWpGaD
Ibuprofen—Constipation—Etoposide—muscle cancer	0.000124	0.00111	CcSEcCtD
Ibuprofen—Dysuria—Doxorubicin—muscle cancer	0.000124	0.0011	CcSEcCtD
Ibuprofen—Neutropenia—Doxorubicin—muscle cancer	0.000124	0.0011	CcSEcCtD
Ibuprofen—Haemoglobin—Methotrexate—muscle cancer	0.000123	0.0011	CcSEcCtD
Ibuprofen—Diarrhoea—Vincristine—muscle cancer	0.000123	0.00109	CcSEcCtD
Ibuprofen—Haemorrhage—Methotrexate—muscle cancer	0.000123	0.00109	CcSEcCtD
Ibuprofen—Hepatitis—Methotrexate—muscle cancer	0.000123	0.00109	CcSEcCtD
Ibuprofen—Pollakiuria—Doxorubicin—muscle cancer	0.000123	0.00109	CcSEcCtD
Ibuprofen—ABCB1—testis—muscle cancer	0.000122	0.00204	CbGeAlD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—MDM2—muscle cancer	0.000122	0.00242	CbGpPWpGaD
Ibuprofen—Pharyngitis—Methotrexate—muscle cancer	0.000122	0.00108	CcSEcCtD
Ibuprofen—Urinary tract disorder—Methotrexate—muscle cancer	0.000121	0.00108	CcSEcCtD
Ibuprofen—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000121	0.00108	CcSEcCtD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—MDM2—muscle cancer	0.000121	0.00239	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—TP53—muscle cancer	0.00012	0.00238	CbGpPWpGaD
Ibuprofen—Urethral disorder—Methotrexate—muscle cancer	0.00012	0.00107	CcSEcCtD
Ibuprofen—Weight decreased—Doxorubicin—muscle cancer	0.00012	0.00107	CcSEcCtD
Ibuprofen—Feeling abnormal—Etoposide—muscle cancer	0.00012	0.00107	CcSEcCtD
Ibuprofen—Hyperglycaemia—Doxorubicin—muscle cancer	0.00012	0.00107	CcSEcCtD
Ibuprofen—Nausea—Dactinomycin—muscle cancer	0.000119	0.00106	CcSEcCtD
Ibuprofen—Pneumonia—Doxorubicin—muscle cancer	0.000119	0.00106	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Etoposide—muscle cancer	0.000119	0.00106	CcSEcCtD
Ibuprofen—Dizziness—Vincristine—muscle cancer	0.000119	0.00106	CcSEcCtD
Ibuprofen—Drowsiness—Doxorubicin—muscle cancer	0.000118	0.00105	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—muscle cancer	0.000118	0.00105	CcSEcCtD
Ibuprofen—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000117	0.00104	CcSEcCtD
Ibuprofen—PTGS1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000116	0.00231	CbGpPWpGaD
Ibuprofen—Renal failure—Doxorubicin—muscle cancer	0.000116	0.00104	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—muscle cancer	0.000116	0.00103	CcSEcCtD
Ibuprofen—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000116	0.00103	CcSEcCtD
Ibuprofen—Urticaria—Etoposide—muscle cancer	0.000116	0.00103	CcSEcCtD
Ibuprofen—Stomatitis—Doxorubicin—muscle cancer	0.000115	0.00103	CcSEcCtD
Ibuprofen—Jaundice—Doxorubicin—muscle cancer	0.000115	0.00103	CcSEcCtD
Ibuprofen—CXCL8—Allograft Rejection—VEGFA—muscle cancer	0.000115	0.00228	CbGpPWpGaD
Ibuprofen—Abdominal pain—Etoposide—muscle cancer	0.000115	0.00102	CcSEcCtD
Ibuprofen—Conjunctivitis—Doxorubicin—muscle cancer	0.000115	0.00102	CcSEcCtD
Ibuprofen—Urinary tract infection—Doxorubicin—muscle cancer	0.000115	0.00102	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—muscle cancer	0.000114	0.00102	CcSEcCtD
Ibuprofen—Vomiting—Vincristine—muscle cancer	0.000114	0.00102	CcSEcCtD
Ibuprofen—Sweating—Doxorubicin—muscle cancer	0.000113	0.00101	CcSEcCtD
Ibuprofen—Rash—Vincristine—muscle cancer	0.000113	0.00101	CcSEcCtD
Ibuprofen—Dermatitis—Vincristine—muscle cancer	0.000113	0.00101	CcSEcCtD
Ibuprofen—Haematuria—Doxorubicin—muscle cancer	0.000113	0.001	CcSEcCtD
Ibuprofen—Headache—Vincristine—muscle cancer	0.000112	0.001	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000112	0.000996	CcSEcCtD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CNR1—muscle cancer	0.000112	0.00221	CbGpPWpGaD
Ibuprofen—Epistaxis—Doxorubicin—muscle cancer	0.000112	0.000993	CcSEcCtD
Ibuprofen—Sinusitis—Doxorubicin—muscle cancer	0.000111	0.000988	CcSEcCtD
Ibuprofen—Immune system disorder—Methotrexate—muscle cancer	0.000111	0.000986	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—muscle cancer	0.00011	0.000984	CcSEcCtD
Ibuprofen—Agranulocytosis—Doxorubicin—muscle cancer	0.00011	0.000983	CcSEcCtD
Ibuprofen—Chills—Methotrexate—muscle cancer	0.00011	0.00098	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—muscle cancer	0.000108	0.000965	CcSEcCtD
Ibuprofen—PLAT—Hemostasis—IGF2—muscle cancer	0.000108	0.00214	CbGpPWpGaD
Ibuprofen—Mental disorder—Methotrexate—muscle cancer	0.000107	0.000957	CcSEcCtD
Ibuprofen—Hypersensitivity—Etoposide—muscle cancer	0.000107	0.000954	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—muscle cancer	0.000107	0.000951	CcSEcCtD
Ibuprofen—Erythema—Methotrexate—muscle cancer	0.000107	0.000951	CcSEcCtD
Ibuprofen—Haemoglobin—Doxorubicin—muscle cancer	0.000107	0.00095	CcSEcCtD
Ibuprofen—Nausea—Vincristine—muscle cancer	0.000107	0.00095	CcSEcCtD
Ibuprofen—Rhinitis—Doxorubicin—muscle cancer	0.000106	0.000948	CcSEcCtD
Ibuprofen—Hepatitis—Doxorubicin—muscle cancer	0.000106	0.000946	CcSEcCtD
Ibuprofen—Haemorrhage—Doxorubicin—muscle cancer	0.000106	0.000946	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—PTGS2—muscle cancer	0.000106	0.0021	CbGpPWpGaD
Ibuprofen—Pharyngitis—Doxorubicin—muscle cancer	0.000105	0.000938	CcSEcCtD
Ibuprofen—Urinary tract disorder—Doxorubicin—muscle cancer	0.000105	0.000934	CcSEcCtD
Ibuprofen—Oedema peripheral—Doxorubicin—muscle cancer	0.000105	0.000931	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—muscle cancer	0.000104	0.000931	CcSEcCtD
Ibuprofen—Asthenia—Etoposide—muscle cancer	0.000104	0.000929	CcSEcCtD
Ibuprofen—Urethral disorder—Doxorubicin—muscle cancer	0.000104	0.000927	CcSEcCtD
Ibuprofen—THBD—Hemostasis—VEGFA—muscle cancer	0.000104	0.00206	CbGpPWpGaD
Ibuprofen—Pruritus—Etoposide—muscle cancer	0.000103	0.000916	CcSEcCtD
Ibuprofen—Visual impairment—Doxorubicin—muscle cancer	0.000102	0.000911	CcSEcCtD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000101	0.00201	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—PTCH1—muscle cancer	0.000101	0.002	CbGpPWpGaD
Ibuprofen—Vision blurred—Methotrexate—muscle cancer	0.000101	0.000896	CcSEcCtD
Ibuprofen—Erythema multiforme—Doxorubicin—muscle cancer	0.0001	0.000894	CcSEcCtD
Ibuprofen—ABCC4—Hemostasis—ANGPT2—muscle cancer	0.0001	0.00199	CbGpPWpGaD
Ibuprofen—BCL2—Direct p53 effectors—MDM2—muscle cancer	9.99e-05	0.00198	CbGpPWpGaD
Ibuprofen—Diarrhoea—Etoposide—muscle cancer	9.95e-05	0.000886	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—muscle cancer	9.9e-05	0.000882	CcSEcCtD
Ibuprofen—Tinnitus—Doxorubicin—muscle cancer	9.9e-05	0.000882	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—muscle cancer	9.86e-05	0.000879	CcSEcCtD
Ibuprofen—ALB—Platelet degranulation—IGF2—muscle cancer	9.64e-05	0.00191	CbGpPWpGaD
Ibuprofen—Malaise—Methotrexate—muscle cancer	9.62e-05	0.000857	CcSEcCtD
Ibuprofen—Dizziness—Etoposide—muscle cancer	9.61e-05	0.000856	CcSEcCtD
Ibuprofen—Immune system disorder—Doxorubicin—muscle cancer	9.59e-05	0.000854	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—muscle cancer	9.59e-05	0.000854	CcSEcCtD
Ibuprofen—CXCL8—AP-1 transcription factor network—TP53—muscle cancer	9.59e-05	0.0019	CbGpPWpGaD
Ibuprofen—Mediastinal disorder—Doxorubicin—muscle cancer	9.57e-05	0.000852	CcSEcCtD
Ibuprofen—Leukopenia—Methotrexate—muscle cancer	9.55e-05	0.000851	CcSEcCtD
Ibuprofen—Chills—Doxorubicin—muscle cancer	9.52e-05	0.000848	CcSEcCtD
Ibuprofen—Arrhythmia—Doxorubicin—muscle cancer	9.48e-05	0.000845	CcSEcCtD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—IGF2—muscle cancer	9.45e-05	0.00187	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—MDM2—muscle cancer	9.4e-05	0.00186	CbGpPWpGaD
Ibuprofen—Alopecia—Doxorubicin—muscle cancer	9.38e-05	0.000836	CcSEcCtD
Ibuprofen—Cough—Methotrexate—muscle cancer	9.31e-05	0.000829	CcSEcCtD
Ibuprofen—Mental disorder—Doxorubicin—muscle cancer	9.3e-05	0.000828	CcSEcCtD
Ibuprofen—Convulsion—Methotrexate—muscle cancer	9.25e-05	0.000824	CcSEcCtD
Ibuprofen—Vomiting—Etoposide—muscle cancer	9.24e-05	0.000823	CcSEcCtD
Ibuprofen—Malnutrition—Doxorubicin—muscle cancer	9.24e-05	0.000823	CcSEcCtD
Ibuprofen—Erythema—Doxorubicin—muscle cancer	9.24e-05	0.000823	CcSEcCtD
Ibuprofen—ALB—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	9.18e-05	0.00182	CbGpPWpGaD
Ibuprofen—Rash—Etoposide—muscle cancer	9.17e-05	0.000817	CcSEcCtD
Ibuprofen—Dermatitis—Etoposide—muscle cancer	9.16e-05	0.000816	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—MYOD1—muscle cancer	9.15e-05	0.00181	CbGpPWpGaD
Ibuprofen—Headache—Etoposide—muscle cancer	9.11e-05	0.000811	CcSEcCtD
Ibuprofen—Flatulence—Doxorubicin—muscle cancer	9.11e-05	0.000811	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—muscle cancer	9.08e-05	0.000809	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—muscle cancer	9.08e-05	0.000809	CcSEcCtD
Ibuprofen—Tension—Doxorubicin—muscle cancer	9.07e-05	0.000808	CcSEcCtD
Ibuprofen—Dysgeusia—Doxorubicin—muscle cancer	9.05e-05	0.000806	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	9.02e-05	0.000804	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—muscle cancer	8.98e-05	0.0008	CcSEcCtD
Ibuprofen—Nervousness—Doxorubicin—muscle cancer	8.97e-05	0.000799	CcSEcCtD
Ibuprofen—ABCC4—Platelet degranulation—VEGFA—muscle cancer	8.93e-05	0.00177	CbGpPWpGaD
Ibuprofen—PPARG—Generic Transcription Pathway—MED12—muscle cancer	8.89e-05	0.00176	CbGpPWpGaD
Ibuprofen—Muscle spasms—Doxorubicin—muscle cancer	8.88e-05	0.000791	CcSEcCtD
Ibuprofen—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	8.84e-05	0.00175	CbGpPWpGaD
Ibuprofen—Confusional state—Methotrexate—muscle cancer	8.78e-05	0.000782	CcSEcCtD
Ibuprofen—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	8.76e-05	0.00174	CbGpPWpGaD
Ibuprofen—Anaphylactic shock—Methotrexate—muscle cancer	8.71e-05	0.000776	CcSEcCtD
Ibuprofen—Vision blurred—Doxorubicin—muscle cancer	8.71e-05	0.000776	CcSEcCtD
Ibuprofen—Infection—Methotrexate—muscle cancer	8.65e-05	0.000771	CcSEcCtD
Ibuprofen—Nausea—Etoposide—muscle cancer	8.64e-05	0.000769	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—TP53—muscle cancer	8.62e-05	0.00171	CbGpPWpGaD
Ibuprofen—Ill-defined disorder—Doxorubicin—muscle cancer	8.57e-05	0.000764	CcSEcCtD
Ibuprofen—Nervous system disorder—Methotrexate—muscle cancer	8.54e-05	0.000761	CcSEcCtD
Ibuprofen—Anaemia—Doxorubicin—muscle cancer	8.54e-05	0.000761	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—muscle cancer	8.53e-05	0.00076	CcSEcCtD
Ibuprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	8.51e-05	0.00169	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR ligand binding—CNR1—muscle cancer	8.5e-05	0.00169	CbGpPWpGaD
Ibuprofen—Agitation—Doxorubicin—muscle cancer	8.49e-05	0.000756	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—muscle cancer	8.46e-05	0.000754	CcSEcCtD
Ibuprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—muscle cancer	8.45e-05	0.00167	CbGpPWpGaD
Ibuprofen—Hyperhidrosis—Methotrexate—muscle cancer	8.42e-05	0.00075	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—MED12—muscle cancer	8.37e-05	0.00166	CbGpPWpGaD
Ibuprofen—Malaise—Doxorubicin—muscle cancer	8.33e-05	0.000742	CcSEcCtD
Ibuprofen—Vertigo—Doxorubicin—muscle cancer	8.3e-05	0.00074	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—muscle cancer	8.3e-05	0.000739	CcSEcCtD
Ibuprofen—Syncope—Doxorubicin—muscle cancer	8.29e-05	0.000738	CcSEcCtD
Ibuprofen—Leukopenia—Doxorubicin—muscle cancer	8.27e-05	0.000737	CcSEcCtD
Ibuprofen—Palpitations—Doxorubicin—muscle cancer	8.17e-05	0.000727	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—muscle cancer	8.14e-05	0.000725	CcSEcCtD
Ibuprofen—Loss of consciousness—Doxorubicin—muscle cancer	8.12e-05	0.000723	CcSEcCtD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—TP53—muscle cancer	8.09e-05	0.0016	CbGpPWpGaD
Ibuprofen—Cough—Doxorubicin—muscle cancer	8.06e-05	0.000718	CcSEcCtD
Ibuprofen—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	8.03e-05	0.00159	CbGpPWpGaD
Ibuprofen—Convulsion—Doxorubicin—muscle cancer	8.01e-05	0.000713	CcSEcCtD
Ibuprofen—Hypertension—Doxorubicin—muscle cancer	7.98e-05	0.000711	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.93e-05	0.000707	CcSEcCtD
Ibuprofen—CXCL8—Cellular Senescence—CDKN2A—muscle cancer	7.88e-05	0.00156	CbGpPWpGaD
Ibuprofen—Insomnia—Methotrexate—muscle cancer	7.88e-05	0.000702	CcSEcCtD
Ibuprofen—Arthralgia—Doxorubicin—muscle cancer	7.87e-05	0.000701	CcSEcCtD
Ibuprofen—Myalgia—Doxorubicin—muscle cancer	7.87e-05	0.000701	CcSEcCtD
Ibuprofen—THBD—Hemostasis—TP53—muscle cancer	7.85e-05	0.00156	CbGpPWpGaD
Ibuprofen—Anxiety—Doxorubicin—muscle cancer	7.84e-05	0.000698	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—muscle cancer	7.82e-05	0.000697	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.81e-05	0.000696	CcSEcCtD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	7.79e-05	0.00154	CbGpPWpGaD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	7.78e-05	0.00154	CbGpPWpGaD
Ibuprofen—Discomfort—Doxorubicin—muscle cancer	7.77e-05	0.000692	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—muscle cancer	7.76e-05	0.000692	CcSEcCtD
Ibuprofen—CXCL8—Signaling Pathways—KIDINS220—muscle cancer	7.76e-05	0.00154	CbGpPWpGaD
Ibuprofen—Somnolence—Methotrexate—muscle cancer	7.74e-05	0.00069	CcSEcCtD
Ibuprofen—UGT2B4—Metabolism—MED12—muscle cancer	7.73e-05	0.00153	CbGpPWpGaD
Ibuprofen—Dry mouth—Doxorubicin—muscle cancer	7.69e-05	0.000685	CcSEcCtD
Ibuprofen—Dyspepsia—Methotrexate—muscle cancer	7.67e-05	0.000683	CcSEcCtD
Ibuprofen—CXCL8—Cellular Senescence—MDM2—muscle cancer	7.65e-05	0.00152	CbGpPWpGaD
Ibuprofen—Confusional state—Doxorubicin—muscle cancer	7.6e-05	0.000677	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—muscle cancer	7.57e-05	0.000674	CcSEcCtD
Ibuprofen—Anaphylactic shock—Doxorubicin—muscle cancer	7.54e-05	0.000672	CcSEcCtD
Ibuprofen—Oedema—Doxorubicin—muscle cancer	7.54e-05	0.000672	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—muscle cancer	7.52e-05	0.00067	CcSEcCtD
Ibuprofen—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	7.51e-05	0.00149	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	7.51e-05	0.00149	CbGpPWpGaD
Ibuprofen—Fatigue—Methotrexate—muscle cancer	7.51e-05	0.000669	CcSEcCtD
Ibuprofen—Infection—Doxorubicin—muscle cancer	7.49e-05	0.000667	CcSEcCtD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.47e-05	0.00148	CbGpPWpGaD
Ibuprofen—Shock—Doxorubicin—muscle cancer	7.42e-05	0.000661	CcSEcCtD
Ibuprofen—PTGS1—Selenium Micronutrient Network—PTGS2—muscle cancer	7.4e-05	0.00147	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	7.4e-05	0.00147	CbGpPWpGaD
Ibuprofen—Nervous system disorder—Doxorubicin—muscle cancer	7.4e-05	0.000659	CcSEcCtD
Ibuprofen—Thrombocytopenia—Doxorubicin—muscle cancer	7.38e-05	0.000658	CcSEcCtD
Ibuprofen—Tachycardia—Doxorubicin—muscle cancer	7.36e-05	0.000656	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—FH—muscle cancer	7.33e-05	0.00145	CbGpPWpGaD
Ibuprofen—Skin disorder—Doxorubicin—muscle cancer	7.32e-05	0.000652	CcSEcCtD
Ibuprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	7.31e-05	0.00145	CbGpPWpGaD
Ibuprofen—Hyperhidrosis—Doxorubicin—muscle cancer	7.29e-05	0.000649	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—FOXO4—muscle cancer	7.26e-05	0.00144	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—TP53—muscle cancer	7.21e-05	0.00143	CbGpPWpGaD
Ibuprofen—Anorexia—Doxorubicin—muscle cancer	7.19e-05	0.00064	CcSEcCtD
Ibuprofen—Feeling abnormal—Methotrexate—muscle cancer	7.18e-05	0.000639	CcSEcCtD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	7.17e-05	0.00142	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—VEGFA—muscle cancer	7.14e-05	0.00142	CbGpPWpGaD
Ibuprofen—Gastrointestinal pain—Methotrexate—muscle cancer	7.12e-05	0.000634	CcSEcCtD
Ibuprofen—UGT2B4—Metabolism—ENO2—muscle cancer	7.05e-05	0.0014	CbGpPWpGaD
Ibuprofen—Hypotension—Doxorubicin—muscle cancer	7.05e-05	0.000628	CcSEcCtD
Ibuprofen—BCL2—DNA Damage Response (only ATM dependent)—TP53—muscle cancer	7e-05	0.00139	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—muscle cancer	6.93e-05	0.00137	CbGpPWpGaD
Ibuprofen—Urticaria—Methotrexate—muscle cancer	6.92e-05	0.000616	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—muscle cancer	6.88e-05	0.000613	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.88e-05	0.00136	CbGpPWpGaD
Ibuprofen—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.87e-05	0.000612	CcSEcCtD
Ibuprofen—Insomnia—Doxorubicin—muscle cancer	6.82e-05	0.000608	CcSEcCtD
Ibuprofen—Paraesthesia—Doxorubicin—muscle cancer	6.77e-05	0.000603	CcSEcCtD
Ibuprofen—Dyspnoea—Doxorubicin—muscle cancer	6.72e-05	0.000599	CcSEcCtD
Ibuprofen—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	6.71e-05	0.00133	CbGpPWpGaD
Ibuprofen—Somnolence—Doxorubicin—muscle cancer	6.7e-05	0.000597	CcSEcCtD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—VEGFA—muscle cancer	6.68e-05	0.00132	CbGpPWpGaD
Ibuprofen—Dyspepsia—Doxorubicin—muscle cancer	6.64e-05	0.000591	CcSEcCtD
Ibuprofen—Decreased appetite—Doxorubicin—muscle cancer	6.56e-05	0.000584	CcSEcCtD
Ibuprofen—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	6.52e-05	0.00129	CbGpPWpGaD
Ibuprofen—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.51e-05	0.00058	CcSEcCtD
Ibuprofen—Fatigue—Doxorubicin—muscle cancer	6.5e-05	0.000579	CcSEcCtD
Ibuprofen—Constipation—Doxorubicin—muscle cancer	6.45e-05	0.000574	CcSEcCtD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.42e-05	0.00127	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Methotrexate—muscle cancer	6.42e-05	0.000572	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—TP53—muscle cancer	6.31e-05	0.00125	CbGpPWpGaD
Ibuprofen—Asthenia—Methotrexate—muscle cancer	6.25e-05	0.000557	CcSEcCtD
Ibuprofen—UGT2B7—Metabolism—FH—muscle cancer	6.23e-05	0.00124	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD34—muscle cancer	6.22e-05	0.00123	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Doxorubicin—muscle cancer	6.21e-05	0.000554	CcSEcCtD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.19e-05	0.00123	CbGpPWpGaD
Ibuprofen—Gastrointestinal pain—Doxorubicin—muscle cancer	6.17e-05	0.000549	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—muscle cancer	6.16e-05	0.000549	CcSEcCtD
Ibuprofen—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	6.12e-05	0.00121	CbGpPWpGaD
Ibuprofen—Urticaria—Doxorubicin—muscle cancer	5.99e-05	0.000534	CcSEcCtD
Ibuprofen—Abdominal pain—Doxorubicin—muscle cancer	5.96e-05	0.000531	CcSEcCtD
Ibuprofen—Diarrhoea—Methotrexate—muscle cancer	5.96e-05	0.000531	CcSEcCtD
Ibuprofen—CXCL8—Cellular responses to stress—CDKN2A—muscle cancer	5.96e-05	0.00118	CbGpPWpGaD
Ibuprofen—BCL2—Focal Adhesion—VEGFA—muscle cancer	5.94e-05	0.00118	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	5.91e-05	0.00117	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—FH—muscle cancer	5.89e-05	0.00117	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—MDM2—muscle cancer	5.78e-05	0.00115	CbGpPWpGaD
Ibuprofen—Dizziness—Methotrexate—muscle cancer	5.76e-05	0.000513	CcSEcCtD
Ibuprofen—BCL2—Direct p53 effectors—TP53—muscle cancer	5.73e-05	0.00114	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Doxorubicin—muscle cancer	5.56e-05	0.000495	CcSEcCtD
Ibuprofen—Vomiting—Methotrexate—muscle cancer	5.54e-05	0.000493	CcSEcCtD
Ibuprofen—Rash—Methotrexate—muscle cancer	5.49e-05	0.000489	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—muscle cancer	5.49e-05	0.000489	CcSEcCtD
Ibuprofen—Headache—Methotrexate—muscle cancer	5.46e-05	0.000486	CcSEcCtD
Ibuprofen—SLCO1A2—Metabolism—FH—muscle cancer	5.43e-05	0.00108	CbGpPWpGaD
Ibuprofen—Asthenia—Doxorubicin—muscle cancer	5.41e-05	0.000482	CcSEcCtD
Ibuprofen—BCL2—Integrated Breast Cancer Pathway—TP53—muscle cancer	5.39e-05	0.00107	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—FOXO1—muscle cancer	5.36e-05	0.00106	CbGpPWpGaD
Ibuprofen—Pruritus—Doxorubicin—muscle cancer	5.34e-05	0.000475	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—PTCH1—muscle cancer	5.3e-05	0.00105	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TP53—muscle cancer	5.28e-05	0.00105	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	5.24e-05	0.00104	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.24e-05	0.00104	CbGpPWpGaD
Ibuprofen—Nausea—Methotrexate—muscle cancer	5.17e-05	0.000461	CcSEcCtD
Ibuprofen—CXCL8—Signaling by GPCR—PTCH1—muscle cancer	5.17e-05	0.00102	CbGpPWpGaD
Ibuprofen—Diarrhoea—Doxorubicin—muscle cancer	5.16e-05	0.00046	CcSEcCtD
Ibuprofen—UGT1A1—Metabolism—FH—muscle cancer	5.06e-05	0.001	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—FH—muscle cancer	5.06e-05	0.001	CbGpPWpGaD
Ibuprofen—Dizziness—Doxorubicin—muscle cancer	4.99e-05	0.000444	CcSEcCtD
Ibuprofen—CXCL8—Metabolism of proteins—IGF2—muscle cancer	4.89e-05	0.00097	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—FH—muscle cancer	4.88e-05	0.000968	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—IGF2—muscle cancer	4.87e-05	0.000965	CbGpPWpGaD
Ibuprofen—CXCL8—GPCR downstream signaling—CNR1—muscle cancer	4.81e-05	0.000953	CbGpPWpGaD
Ibuprofen—Vomiting—Doxorubicin—muscle cancer	4.79e-05	0.000427	CcSEcCtD
Ibuprofen—Rash—Doxorubicin—muscle cancer	4.75e-05	0.000424	CcSEcCtD
Ibuprofen—ALB—Selenium Micronutrient Network—PTGS2—muscle cancer	4.75e-05	0.000942	CbGpPWpGaD
Ibuprofen—Dermatitis—Doxorubicin—muscle cancer	4.75e-05	0.000423	CcSEcCtD
Ibuprofen—Headache—Doxorubicin—muscle cancer	4.72e-05	0.000421	CcSEcCtD
Ibuprofen—PPARG—Developmental Biology—FOXO1—muscle cancer	4.59e-05	0.000911	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—FOXO4—muscle cancer	4.55e-05	0.000903	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—ANGPT2—muscle cancer	4.53e-05	0.000898	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—VEGFA—muscle cancer	4.52e-05	0.000896	CbGpPWpGaD
Ibuprofen—Nausea—Doxorubicin—muscle cancer	4.48e-05	0.000399	CcSEcCtD
Ibuprofen—PLAT—Signaling Pathways—CNR1—muscle cancer	4.47e-05	0.000886	CbGpPWpGaD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	4.47e-05	0.000886	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—VEGFA—muscle cancer	4.39e-05	0.00087	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—TP53—muscle cancer	4.39e-05	0.00087	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—CNR1—muscle cancer	4.36e-05	0.000865	CbGpPWpGaD
Ibuprofen—PPARG—Gene Expression—MED12—muscle cancer	4.28e-05	0.000849	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—IGF2—muscle cancer	4.27e-05	0.000847	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—FOXO4—muscle cancer	4.23e-05	0.000838	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.16e-05	0.000824	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—MED12—muscle cancer	4.14e-05	0.000821	CbGpPWpGaD
Ibuprofen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	4.13e-05	0.000819	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—FH—muscle cancer	4.13e-05	0.000818	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—KIT—muscle cancer	4.08e-05	0.00081	CbGpPWpGaD
Ibuprofen—ALB—Platelet degranulation—VEGFA—muscle cancer	4.04e-05	0.000801	CbGpPWpGaD
Ibuprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.96e-05	0.000785	CbGpPWpGaD
Ibuprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	3.85e-05	0.000763	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—ENO2—muscle cancer	3.77e-05	0.000748	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—IGF2—muscle cancer	3.65e-05	0.000724	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—VEGFA—muscle cancer	3.58e-05	0.000709	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TP53—muscle cancer	3.56e-05	0.000706	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—MED12—muscle cancer	3.52e-05	0.000698	CbGpPWpGaD
Ibuprofen—PLAT—Hemostasis—TP53—muscle cancer	3.42e-05	0.000677	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.38e-05	0.000671	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.36e-05	0.000667	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—FOXO1—muscle cancer	3.36e-05	0.000667	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—MED12—muscle cancer	3.33e-05	0.00066	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular responses to stress—TP53—muscle cancer	3.31e-05	0.000657	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	3.28e-05	0.00065	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—FH—muscle cancer	3.28e-05	0.00065	CbGpPWpGaD
Ibuprofen—PPARG—Circadian rythm related genes—TP53—muscle cancer	3.25e-05	0.000644	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—MDM2—muscle cancer	3.22e-05	0.000638	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—ENO2—muscle cancer	3.21e-05	0.000636	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—FOXO1—muscle cancer	3.12e-05	0.000619	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—MED12—muscle cancer	3.07e-05	0.000608	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTCH1—muscle cancer	3.05e-05	0.000605	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—ENO2—muscle cancer	3.03e-05	0.000602	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.02e-05	0.000599	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—ENO2—muscle cancer	3e-05	0.000595	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—MED12—muscle cancer	2.86e-05	0.000567	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—MED12—muscle cancer	2.86e-05	0.000567	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—ENO2—muscle cancer	2.79e-05	0.000554	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TP53—muscle cancer	2.77e-05	0.000548	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—MED12—muscle cancer	2.76e-05	0.000547	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.75e-05	0.000546	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HMGA1—muscle cancer	2.73e-05	0.000541	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—FH—muscle cancer	2.67e-05	0.000528	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—FH—muscle cancer	2.65e-05	0.000525	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—FOXO4—muscle cancer	2.63e-05	0.000521	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—ENO2—muscle cancer	2.61e-05	0.000517	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—ENO2—muscle cancer	2.61e-05	0.000517	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—CNR1—muscle cancer	2.58e-05	0.000511	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—KIT—muscle cancer	2.56e-05	0.000508	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—ENO2—muscle cancer	2.51e-05	0.000499	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.49e-05	0.000494	CbGpPWpGaD
Ibuprofen—UGT2B4—Metabolism—PTGS2—muscle cancer	2.45e-05	0.000487	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—FOXO4—muscle cancer	2.45e-05	0.000485	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—FH—muscle cancer	2.38e-05	0.000472	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KIT—muscle cancer	2.38e-05	0.000472	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.37e-05	0.000471	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—MED12—muscle cancer	2.33e-05	0.000462	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.32e-05	0.000461	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—FH—muscle cancer	2.32e-05	0.00046	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.24e-05	0.000444	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—IGF2—muscle cancer	2.2e-05	0.000437	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.19e-05	0.000433	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—FH—muscle cancer	2.17e-05	0.00043	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—ENO2—muscle cancer	2.13e-05	0.000421	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—IGF2—muscle cancer	2.11e-05	0.000418	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—VEGFA—muscle cancer	2.09e-05	0.000415	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—VEGFA—muscle cancer	2.04e-05	0.000405	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.04e-05	0.000404	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—MDM2—muscle cancer	2.02e-05	0.0004	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ENO2—muscle cancer	2.02e-05	0.0004	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.97e-05	0.00039	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—FOXO1—muscle cancer	1.94e-05	0.000385	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.88e-05	0.000373	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—MDM2—muscle cancer	1.87e-05	0.000371	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—MED12—muscle cancer	1.85e-05	0.000367	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HMGA1—muscle cancer	1.83e-05	0.000363	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—FOXO1—muscle cancer	1.81e-05	0.000358	CbGpPWpGaD
Ibuprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	1.79e-05	0.000355	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.77e-05	0.00035	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—ENO2—muscle cancer	1.69e-05	0.000335	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.66e-05	0.00033	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—FOXO4—muscle cancer	1.64e-05	0.000326	CbGpPWpGaD
Ibuprofen—ABCC4—Hemostasis—TP53—muscle cancer	1.54e-05	0.000306	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—VEGFA—muscle cancer	1.53e-05	0.000304	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—MED12—muscle cancer	1.51e-05	0.000299	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—MED12—muscle cancer	1.5e-05	0.000297	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—KIT—muscle cancer	1.48e-05	0.000293	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—KIT—muscle cancer	1.38e-05	0.000273	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—ENO2—muscle cancer	1.37e-05	0.000272	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—ENO2—muscle cancer	1.37e-05	0.000271	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—MED12—muscle cancer	1.34e-05	0.000267	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.33e-05	0.000264	CbGpPWpGaD
Ibuprofen—UGT1A3—Metabolism—PTGS2—muscle cancer	1.31e-05	0.000261	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—MED12—muscle cancer	1.31e-05	0.00026	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—MED12—muscle cancer	1.23e-05	0.000243	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—ENO2—muscle cancer	1.23e-05	0.000243	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—FOXO1—muscle cancer	1.21e-05	0.000241	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—ENO2—muscle cancer	1.2e-05	0.000237	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MDM2—muscle cancer	1.16e-05	0.000231	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—TP53—muscle cancer	1.16e-05	0.00023	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—PTGS2—muscle cancer	1.12e-05	0.000222	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—ENO2—muscle cancer	1.12e-05	0.000222	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—MDM2—muscle cancer	1.08e-05	0.000215	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.07e-05	0.000213	CbGpPWpGaD
Ibuprofen—ALB—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.07e-05	0.000212	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—PTGS2—muscle cancer	1.06e-05	0.00021	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—PTGS2—muscle cancer	1.05e-05	0.000207	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—PTGS2—muscle cancer	9.73e-06	0.000193	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.59e-06	0.00019	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—KIT—muscle cancer	9.25e-06	0.000183	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—VEGFA—muscle cancer	9.24e-06	0.000183	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—PTGS2—muscle cancer	9.08e-06	0.00018	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—PTGS2—muscle cancer	9.08e-06	0.00018	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—VEGFA—muscle cancer	8.84e-06	0.000175	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—PTGS2—muscle cancer	8.76e-06	0.000174	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.74e-06	0.000173	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—PTGS2—muscle cancer	7.4e-06	0.000147	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—MDM2—muscle cancer	7.28e-06	0.000144	CbGpPWpGaD
Ibuprofen—ALB—Hemostasis—TP53—muscle cancer	6.98e-06	0.000138	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—TP53—muscle cancer	6.68e-06	0.000132	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—PTGS2—muscle cancer	4.78e-06	9.48e-05	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—PTGS2—muscle cancer	4.76e-06	9.43e-05	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—PTGS2—muscle cancer	4.27e-06	8.46e-05	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—PTGS2—muscle cancer	4.17e-06	8.26e-05	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—PTGS2—muscle cancer	3.89e-06	7.72e-05	CbGpPWpGaD
